Foster City, CA, United States of America

Chingwei Vivian Lee

USPTO Granted Patents = 21 (Patent Applications = 9)

CIPO Patents = 3 (Patent Applications = 4)

EPO Patents = 4 (Patent Applications = 9)

Average Co-Inventor Count = 4.2

ph-index = 4

Forward Citations = 65(Granted Patents)

Company Filing History:

Years Active: 2010-2025

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12365732 - Anti-CD96 antibodies and methods of use thereof (2025-07-22),

2. 12121586 - Optimized variants of anti-VEGF antibodies (2024-10-22),

3. 12006360 - Dual specific antibodies for binding interleukin 4 (IL4) and interleukin 5 (IL5) (2024-06-11),

4. 11891437 - Methods of treating ocular disorders by administering a VEGF-binding antibody covalently linked to a hyaluronic acid polymer (2024-02-06),

5. 11884719 - Anti-IL-36 antibodies and methods of use thereof (2024-01-30),

6. 11555073 - Anti-CD96 antibodies and methods of use thereof (2023-01-17),

7. 11512143 - Anti-HtrA1 antibodies and methods of use thereof (2022-11-29),

8. 11111291 - Conjugates comprising a vascular endothelial growth factor (VEGF) antibody and a hyaluronic acid polymer (2021-09-07),

9. 11007267 - Anti-CD3 antibodies and methods of use (2021-05-18),

10. 10906968 - Polynucleotides encoding optimized variants of anti-VEGF antibodies (2021-02-02),

11. 10899828 - Optimized variants of anti-vegf antibodies and methods of use thereof in treatment (2021-01-26),

12. 10683348 - Dual specific antibodies (2020-06-16),

13. 10421822 - Anti-HtrA1 antibodies and methods of use thereof (2019-09-24),

14. 10421821 - Anti-HtrA1 antibodies and methods of use thereof (2019-09-24),

15. 10072075 - Optimized variants of anti-VEGF antibodies and methods of treatment thereof by reducing or inhibiting angiogenesis (2018-09-11),

Title: Chingwei Vivian Lee: Pioneering Innovations in the Tech World

Introduction:

Chingwei Vivian Lee is a visionary inventor whose passion for innovation and relentless pursuit of technological excellence have established him as a trailblazer in the ever-evolving tech landscape. Based in Foster City, CA, Lee has made significant contributions to the field of technology with a remarkable portfolio of 18 patents.

Latest Patents:

Lee's latest patents showcase his cutting-edge approach to addressing critical medical needs. His inventions include methods of treating ocular disorders by administering a VEGF-binding antibody covalently linked to a hyaluronic acid polymer, aimed at revolutionizing the treatment of disorders associated with pathological angiogenesis. Additionally, he has developed anti-IL-36 antibodies and methods to block IL-36 stimulated signaling pathways, offering innovative solutions in the realm of immunotherapy.

Career Highlights:

With a solid foundation in the tech industry, Lee has held key positions in renowned companies such as Genentech, Inc. and Genetech, Inc. His expertise and innovative mindset have propelled him to spearhead groundbreaking projects, showcasing his ability to drive technological advancements that make a difference in people's lives.

Collaborations:

Throughout his career, Lee has collaborated with esteemed professionals in the field, including Germaine G Fuh and Patrick Koenig. These collaborations have not only enhanced his creative processes but have also led to the development of transformative technologies that have set new benchmarks in the industry.

Conclusion:

In conclusion, Chingwei Vivian Lee's commitment to innovation and his remarkable track record of patenting groundbreaking technologies underscore his status as a visionary inventor in the tech world. His relentless pursuit of excellence continues to shape the future of technology, inspiring generations to come.

This text is generated by artificial intelligence and may not be accurate.